Everything about Healthcare News
FTC sues significant pharmacy benefit managers over insulin prices The agency brought motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of existence-saving insulin medication.Insurers will continue on vertically integrating to main